{"id":9399,"date":"2021-03-26T17:26:51","date_gmt":"2021-03-26T23:26:51","guid":{"rendered":"https:\/\/comunicacion.uaa.mx\/revista\/?p=9399"},"modified":"2021-03-25T17:28:13","modified_gmt":"2021-03-25T23:28:13","slug":"la-infeccion-por-sars-cov-2-se-trata-y-previene-con-eidd-2801","status":"publish","type":"post","link":"https:\/\/comunicacion.uaa.mx\/revista\/?p=9399","title":{"rendered":"La Infecci\u00f3n por SARS-CoV-2 Se Trata y Previene con Eidd-2801"},"content":{"rendered":"<p style=\"text-align: justify;\">Los cient\u00edficos de la Facultad de Medicina de la Universidad de Carolina del Norte, han demostrado que el antiviral EIDD-2801 ofrece una respuesta eficaz contra la infecci\u00f3n por SARS-CoV-2. La administraci\u00f3n terap\u00e9utica y profil\u00e1ctica del antiviral oral de amplio espectro, actualmente en ensayos cl\u00ednicos de fase II-III, inhibi\u00f3 significativamente la replicaci\u00f3n del SARS-CoV-2 in vivo y, por lo tanto, tiene un potencial significativo para la prevenci\u00f3n y el tratamiento de la COVID-19.<\/p>\n<p style=\"text-align: justify;\">Desde el comienzo de la pandemia, los m\u00e9dicos han aplicado diversas t\u00e9cnicas para encontrar un medicamento exitoso, por lo que, los laboratorios realizan varias investigaciones para encontrar una cura. Se buscaba que alg\u00fan antigripal funcionara contra el COVID-19. En meses pasados, concretamente en el 2020, a\u00fan hab\u00eda mucha desinformaci\u00f3n sobre la vacuna o f\u00e1rmacos que pudieran solucionar los malestares o incluso acabar con el virus.<\/p>\n<p style=\"text-align: justify;\">Se est\u00e1 utilizando una plataforma experimental basada en ratones implantados con tejido de pulm\u00f3n humano (LoM) para demostrar la replicaci\u00f3n in vivo eficiente de todos los coronavirus humanos recientemente surgidos (SARS-CoV, MERS-CoV y SARS-CoV-2) y dos virus preend\u00f3genos, coronavirus pand\u00e9mico de murci\u00e9lagos similar al SARS.<\/p>\n<p style=\"text-align: justify;\">La replicaci\u00f3n del virus en este modelo ocurre en tejido pulmonar humano genuino y no requiere ning\u00fan virus o adaptaci\u00f3n del hu\u00e9sped, los resultados arrojados indican que los murci\u00e9lagos albergan coronavirus end\u00f3genos capaces de transmitirse directamente a los humanos.<\/p>\n<p style=\"text-align: justify;\">Un an\u00e1lisis m\u00e1s detallado de la infecci\u00f3n pand\u00e9mica in vivo por SARS-CoV-2 de tejido pulmonar LoM humano, mostr\u00f3 una infecci\u00f3n predominante de c\u00e9lulas epiteliales pulmonares humanas, incluidos neumocitos de tipo II presentes en los alv\u00e9olos y las c\u00e9lulas ciliadas de las v\u00edas respiratorias. respiratorio.<\/p>\n<p style=\"text-align: justify;\">La infecci\u00f3n aguda por SARS-CoV-2 fue altamente citop\u00e1tica, induciendo un interfer\u00f3n tipo I robusto y sostenido y una respuesta inflamatoria de citocinas\/quimiocinas. Finalmente, se est\u00e1 evaluando una estrategia de profilaxis terap\u00e9utica y preexposici\u00f3n para la infecci\u00f3n por coronavirus.<\/p>\n<p style=\"text-align: justify;\">(Mauricio Diosymar Ram\u00edrez Prieto, LCI, 2\u00ba Semestre)<\/p>\n<div class=\"likebtn_container\" style=\"\"><!-- LikeBtn.com BEGIN --><span class=\"likebtn-wrapper\"  data-identifier=\"post_9399\"  data-lang=\"es\"  data-style=\"\"  data-unlike_allowed=\"\"  data-show_copyright=\"\"  data-item_url=\"https:\/\/comunicacion.uaa.mx\/revista\/?p=9399\"  data-item_title=\"La Infecci\u00f3n por SARS-CoV-2 Se Trata y Previene con Eidd-2801\"  data-item_image=\"https:\/\/comunicacion.uaa.mx\/revista\/wp-content\/uploads\/2021\/03\/Cvin.jpg\"  data-item_date=\"2021-03-26T17:26:51-06:00\"  data-engine=\"WordPress\"  data-plugin_v=\"2.6.64\"  data-event_handler=\"likebtn_eh\" ><\/span><!-- LikeBtn.com END --><\/div>","protected":false},"excerpt":{"rendered":"<p>Los cient&iacute;ficos de la Facultad de Medicina de la Universidad de Carolina del Norte, han demostrado que el antiviral EIDD-2801 ofrece una respuesta eficaz contra la infecci&oacute;n por SARS-CoV-2. La administraci&oacute;n terap&eacute;utica y profil&aacute;ctica del antiviral oral de amplio espectro, actualmente en ensayos cl&iacute;nicos de fase II-III, inhibi&oacute; significativamente la replicaci&oacute;n del SARS-CoV-2 in vivo&#8230;<\/p>\n<div class=\"likebtn_container\" style=\"\"><!-- LikeBtn.com BEGIN --><span class=\"likebtn-wrapper\"  data-identifier=\"post_9399\"  data-lang=\"es\"  data-style=\"\"  data-unlike_allowed=\"\"  data-show_copyright=\"\"  data-item_url=\"https:\/\/comunicacion.uaa.mx\/revista\/?p=9399\"  data-item_title=\"La Infecci\u00f3n por SARS-CoV-2 Se Trata y Previene con Eidd-2801\"  data-item_image=\"https:\/\/comunicacion.uaa.mx\/revista\/wp-content\/uploads\/2021\/03\/Cvin.jpg\"  data-item_date=\"2021-03-26T17:26:51-06:00\"  data-engine=\"WordPress\"  data-plugin_v=\"2.6.64\"  data-event_handler=\"likebtn_eh\" ><\/span><!-- LikeBtn.com END --><\/div>","protected":false},"author":102,"featured_media":9422,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"_kad_post_classname":"","footnotes":""},"categories":[4],"tags":[2876,1828,2875,1956,2024],"class_list":["post-9399","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cyt","tag-busqueda","tag-covid-19","tag-farmacos","tag-lucha","tag-pandemia"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>La Infecci\u00f3n por SARS-CoV-2 Se Trata y Previene con Eidd-2801 - Noticias<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/comunicacion.uaa.mx\/revista\/?p=9399\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La Infecci\u00f3n por SARS-CoV-2 Se Trata y Previene con Eidd-2801 - Noticias\" \/>\n<meta property=\"og:description\" content=\"Los cient&iacute;ficos de la Facultad de Medicina de la Universidad de Carolina del Norte, han demostrado que el antiviral EIDD-2801 ofrece una respuesta eficaz contra la infecci&oacute;n por SARS-CoV-2. La administraci&oacute;n terap&eacute;utica y profil&aacute;ctica del antiviral oral de amplio espectro, actualmente en ensayos cl&iacute;nicos de fase II-III, inhibi&oacute; significativamente la replicaci&oacute;n del SARS-CoV-2 in vivo...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/comunicacion.uaa.mx\/revista\/?p=9399\" \/>\n<meta property=\"og:site_name\" content=\"Noticias\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/locusuaa\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-26T23:26:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/comunicacion.uaa.mx\/revista\/wp-content\/uploads\/2021\/03\/Cvin.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"910\" \/>\n\t<meta property=\"og:image:height\" content=\"510\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Locus\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Locus\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/comunicacion.uaa.mx\\\/revista\\\/?p=9399#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/comunicacion.uaa.mx\\\/revista\\\/?p=9399\"},\"author\":{\"name\":\"Locus\",\"@id\":\"https:\\\/\\\/comunicacion.uaa.mx\\\/revista\\\/#\\\/schema\\\/person\\\/edd94b6c92ba473e8995a43ef6b28896\"},\"headline\":\"La Infecci\u00f3n por SARS-CoV-2 Se Trata y Previene con Eidd-2801\",\"datePublished\":\"2021-03-26T23:26:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/comunicacion.uaa.mx\\\/revista\\\/?p=9399\"},\"wordCount\":362,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/comunicacion.uaa.mx\\\/revista\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/comunicacion.uaa.mx\\\/revista\\\/?p=9399#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/comunicacion.uaa.mx\\\/revista\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/Cvin.jpg\",\"keywords\":[\"B\u00fasqueda\",\"COVID-19\",\"Farmacos\",\"Lucha\",\"Pandemia\"],\"articleSection\":[\"Ciencia y tecnolog\u00edas\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/comunicacion.uaa.mx\\\/revista\\\/?p=9399\",\"url\":\"https:\\\/\\\/comunicacion.uaa.mx\\\/revista\\\/?p=9399\",\"name\":\"La Infecci\u00f3n por SARS-CoV-2 Se Trata y Previene con Eidd-2801 - Noticias\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/comunicacion.uaa.mx\\\/revista\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/comunicacion.uaa.mx\\\/revista\\\/?p=9399#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/comunicacion.uaa.mx\\\/revista\\\/?p=9399#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/comunicacion.uaa.mx\\\/revista\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/Cvin.jpg\",\"datePublished\":\"2021-03-26T23:26:51+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/comunicacion.uaa.mx\\\/revista\\\/?p=9399#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/comunicacion.uaa.mx\\\/revista\\\/?p=9399\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/comunicacion.uaa.mx\\\/revista\\\/?p=9399#primaryimage\",\"url\":\"https:\\\/\\\/comunicacion.uaa.mx\\\/revista\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/Cvin.jpg\",\"contentUrl\":\"https:\\\/\\\/comunicacion.uaa.mx\\\/revista\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/Cvin.jpg\",\"width\":910,\"height\":510},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/comunicacion.uaa.mx\\\/revista\\\/?p=9399#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inicio\",\"item\":\"https:\\\/\\\/comunicacion.uaa.mx\\\/revista\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"La Infecci\u00f3n por SARS-CoV-2 Se Trata y Previene con Eidd-2801\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/comunicacion.uaa.mx\\\/revista\\\/#website\",\"url\":\"https:\\\/\\\/comunicacion.uaa.mx\\\/revista\\\/\",\"name\":\"Laboratorio Universitario de Periodismo\",\"description\":\"Laboratorio de Periodismo Universitario\",\"publisher\":{\"@id\":\"https:\\\/\\\/comunicacion.uaa.mx\\\/revista\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/comunicacion.uaa.mx\\\/revista\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/comunicacion.uaa.mx\\\/revista\\\/#organization\",\"name\":\"Locus\",\"url\":\"https:\\\/\\\/comunicacion.uaa.mx\\\/revista\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/comunicacion.uaa.mx\\\/revista\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/comunicacion.uaa.mx\\\/revista\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/cropped-Nuevo-logo-1.png\",\"contentUrl\":\"https:\\\/\\\/comunicacion.uaa.mx\\\/revista\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/cropped-Nuevo-logo-1.png\",\"width\":1963,\"height\":836,\"caption\":\"Locus\"},\"image\":{\"@id\":\"https:\\\/\\\/comunicacion.uaa.mx\\\/revista\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/locusuaa\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/comunicacion.uaa.mx\\\/revista\\\/#\\\/schema\\\/person\\\/edd94b6c92ba473e8995a43ef6b28896\",\"name\":\"Locus\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/267c4dc3149d903514441a71bfda45cc08867cfa990ad5590d0f35f24cb21a81?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/267c4dc3149d903514441a71bfda45cc08867cfa990ad5590d0f35f24cb21a81?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/267c4dc3149d903514441a71bfda45cc08867cfa990ad5590d0f35f24cb21a81?s=96&d=mm&r=g\",\"caption\":\"Locus\"},\"url\":\"https:\\\/\\\/comunicacion.uaa.mx\\\/revista\\\/?author=102\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"La Infecci\u00f3n por SARS-CoV-2 Se Trata y Previene con Eidd-2801 - Noticias","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/comunicacion.uaa.mx\/revista\/?p=9399","og_locale":"es_MX","og_type":"article","og_title":"La Infecci\u00f3n por SARS-CoV-2 Se Trata y Previene con Eidd-2801 - Noticias","og_description":"Los cient&iacute;ficos de la Facultad de Medicina de la Universidad de Carolina del Norte, han demostrado que el antiviral EIDD-2801 ofrece una respuesta eficaz contra la infecci&oacute;n por SARS-CoV-2. La administraci&oacute;n terap&eacute;utica y profil&aacute;ctica del antiviral oral de amplio espectro, actualmente en ensayos cl&iacute;nicos de fase II-III, inhibi&oacute; significativamente la replicaci&oacute;n del SARS-CoV-2 in vivo...","og_url":"https:\/\/comunicacion.uaa.mx\/revista\/?p=9399","og_site_name":"Noticias","article_publisher":"https:\/\/www.facebook.com\/locusuaa","article_published_time":"2021-03-26T23:26:51+00:00","og_image":[{"width":910,"height":510,"url":"https:\/\/comunicacion.uaa.mx\/revista\/wp-content\/uploads\/2021\/03\/Cvin.jpg","type":"image\/jpeg"}],"author":"Locus","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Locus","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/comunicacion.uaa.mx\/revista\/?p=9399#article","isPartOf":{"@id":"https:\/\/comunicacion.uaa.mx\/revista\/?p=9399"},"author":{"name":"Locus","@id":"https:\/\/comunicacion.uaa.mx\/revista\/#\/schema\/person\/edd94b6c92ba473e8995a43ef6b28896"},"headline":"La Infecci\u00f3n por SARS-CoV-2 Se Trata y Previene con Eidd-2801","datePublished":"2021-03-26T23:26:51+00:00","mainEntityOfPage":{"@id":"https:\/\/comunicacion.uaa.mx\/revista\/?p=9399"},"wordCount":362,"commentCount":0,"publisher":{"@id":"https:\/\/comunicacion.uaa.mx\/revista\/#organization"},"image":{"@id":"https:\/\/comunicacion.uaa.mx\/revista\/?p=9399#primaryimage"},"thumbnailUrl":"https:\/\/comunicacion.uaa.mx\/revista\/wp-content\/uploads\/2021\/03\/Cvin.jpg","keywords":["B\u00fasqueda","COVID-19","Farmacos","Lucha","Pandemia"],"articleSection":["Ciencia y tecnolog\u00edas"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/comunicacion.uaa.mx\/revista\/?p=9399","url":"https:\/\/comunicacion.uaa.mx\/revista\/?p=9399","name":"La Infecci\u00f3n por SARS-CoV-2 Se Trata y Previene con Eidd-2801 - Noticias","isPartOf":{"@id":"https:\/\/comunicacion.uaa.mx\/revista\/#website"},"primaryImageOfPage":{"@id":"https:\/\/comunicacion.uaa.mx\/revista\/?p=9399#primaryimage"},"image":{"@id":"https:\/\/comunicacion.uaa.mx\/revista\/?p=9399#primaryimage"},"thumbnailUrl":"https:\/\/comunicacion.uaa.mx\/revista\/wp-content\/uploads\/2021\/03\/Cvin.jpg","datePublished":"2021-03-26T23:26:51+00:00","breadcrumb":{"@id":"https:\/\/comunicacion.uaa.mx\/revista\/?p=9399#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/comunicacion.uaa.mx\/revista\/?p=9399"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/comunicacion.uaa.mx\/revista\/?p=9399#primaryimage","url":"https:\/\/comunicacion.uaa.mx\/revista\/wp-content\/uploads\/2021\/03\/Cvin.jpg","contentUrl":"https:\/\/comunicacion.uaa.mx\/revista\/wp-content\/uploads\/2021\/03\/Cvin.jpg","width":910,"height":510},{"@type":"BreadcrumbList","@id":"https:\/\/comunicacion.uaa.mx\/revista\/?p=9399#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inicio","item":"https:\/\/comunicacion.uaa.mx\/revista\/"},{"@type":"ListItem","position":2,"name":"La Infecci\u00f3n por SARS-CoV-2 Se Trata y Previene con Eidd-2801"}]},{"@type":"WebSite","@id":"https:\/\/comunicacion.uaa.mx\/revista\/#website","url":"https:\/\/comunicacion.uaa.mx\/revista\/","name":"Laboratorio Universitario de Periodismo","description":"Laboratorio de Periodismo Universitario","publisher":{"@id":"https:\/\/comunicacion.uaa.mx\/revista\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/comunicacion.uaa.mx\/revista\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/comunicacion.uaa.mx\/revista\/#organization","name":"Locus","url":"https:\/\/comunicacion.uaa.mx\/revista\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/comunicacion.uaa.mx\/revista\/#\/schema\/logo\/image\/","url":"https:\/\/comunicacion.uaa.mx\/revista\/wp-content\/uploads\/2026\/05\/cropped-Nuevo-logo-1.png","contentUrl":"https:\/\/comunicacion.uaa.mx\/revista\/wp-content\/uploads\/2026\/05\/cropped-Nuevo-logo-1.png","width":1963,"height":836,"caption":"Locus"},"image":{"@id":"https:\/\/comunicacion.uaa.mx\/revista\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/locusuaa"]},{"@type":"Person","@id":"https:\/\/comunicacion.uaa.mx\/revista\/#\/schema\/person\/edd94b6c92ba473e8995a43ef6b28896","name":"Locus","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/267c4dc3149d903514441a71bfda45cc08867cfa990ad5590d0f35f24cb21a81?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/267c4dc3149d903514441a71bfda45cc08867cfa990ad5590d0f35f24cb21a81?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/267c4dc3149d903514441a71bfda45cc08867cfa990ad5590d0f35f24cb21a81?s=96&d=mm&r=g","caption":"Locus"},"url":"https:\/\/comunicacion.uaa.mx\/revista\/?author=102"}]}},"_links":{"self":[{"href":"https:\/\/comunicacion.uaa.mx\/revista\/index.php?rest_route=\/wp\/v2\/posts\/9399","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/comunicacion.uaa.mx\/revista\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/comunicacion.uaa.mx\/revista\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/comunicacion.uaa.mx\/revista\/index.php?rest_route=\/wp\/v2\/users\/102"}],"replies":[{"embeddable":true,"href":"https:\/\/comunicacion.uaa.mx\/revista\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=9399"}],"version-history":[{"count":2,"href":"https:\/\/comunicacion.uaa.mx\/revista\/index.php?rest_route=\/wp\/v2\/posts\/9399\/revisions"}],"predecessor-version":[{"id":9423,"href":"https:\/\/comunicacion.uaa.mx\/revista\/index.php?rest_route=\/wp\/v2\/posts\/9399\/revisions\/9423"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/comunicacion.uaa.mx\/revista\/index.php?rest_route=\/wp\/v2\/media\/9422"}],"wp:attachment":[{"href":"https:\/\/comunicacion.uaa.mx\/revista\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=9399"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/comunicacion.uaa.mx\/revista\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=9399"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/comunicacion.uaa.mx\/revista\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=9399"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}